Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 The City Dr
Orange, CA 92868Phone+1 714-456-8000Fax+1 855-211-3729- Is this information wrong?
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 1992 - 1995
Westchester Medical CenterResidency, Internal Medicine, 1989 - 1992
M.G.M. Medical CollegeClass of 1982
Certifications & Licensure
CA State Medical License Active through 2024- Board CertificationBoard Certified in Oncology
Awards, Honors, & Recognition
- castle connolly
- Top Doctor Castle Connolly, 2014-2019
- Exceptional Women in Medicine Castle Connolly, 2017-2018
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab Start of enrollment: 2015 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, ...Chang, J., Ziogas, A., Kansal, K., Ubbaonu, C., Mehta, R., Zell, J.> ;Cancers. 2023 Nov 26
- Effects ofandgenotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, Christina L Gersch, Ted A Vandenberg, Kathy S Albain, Shaker R Dakhil, Nagendra R Tirumali, Julie R Gralow, G...> ;Pharmacogenomics. 2023 Aug 1
- 2 citationsThymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).Mattias Bergqvist, Adrian Nordmark, Amy Williams, Costanza Paoletti, William Barlow, Erin F Cobain, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain,...> ;Biomarkers. 2023 May 1
- Join now to see all
Committees
- Member, SWOG Breast translational Committee 2017 - Present
- Member, Breast committee and Member, Breast working group, SWOG 2001 - Present
- Member, CTPRMC 2009 - 2019
Professional Memberships
- Member
Hospital Affiliations
UCI HealthOrange, California
Industry Relationships
- Advisory Board, NovartisAdvisory boardDisclosure: Novartis2019 - 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
